Page last updated: 2024-10-26

stallimycin and Alzheimer Disease

stallimycin has been researched along with Alzheimer Disease in 1 studies

Alzheimer Disease: A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kittler, L1
Matesoi, D1
Bell, A1
Baguley, BC1
Unger, E1
Löber, G1

Other Studies

1 other study available for stallimycin and Alzheimer Disease

ArticleYear
Sequence-specific interactions of minor groove binders with the 154 base pair HindIII-RsaI restriction fragment of cDNA of the human Tau 40 protein involved in pathology of Alzheimer's disease.
    Biochemistry and molecular biology international, 1997, Volume: 41, Issue:1

    Topics: Alzheimer Disease; Base Sequence; Binding Sites; Deoxyribonuclease HindIII; Deoxyribonucleases, Type

1997